Evidence map›Paper›PMID 42756818›Full record

ArticleACS omega2026

Synthesis and Fundamental Evaluation of [

Takeshi Chiga, Takeshi Fuchigami, Akari Matsuura, Masayuki Munekane, Kenji Mishiro, Sakura Yoshida, Makoto Oba, Hiroshi Wakabayashi, Seigo Kinuya, Kazuma Ogawa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Takeshi ChigaGraduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan.
Takeshi FuchigamiGraduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan.ORCID https://orcid.org/0000-0001-8141-1212
Akari MatsuuraDepartment of Nuclear Engineering, Graduate School of Engineering, Kyoto University, Kyoto daigaku-Katsura C3, Nishikyo-ku, Kyoto 615-8540, Japan.
Masayuki MunekaneGraduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan.ORCID https://orcid.org/0000-0002-3405-4512
Kenji MishiroGraduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan.ORCID https://orcid.org/0000-0002-5071-7574
Sakura YoshidaGraduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan.
Makoto ObaFaculty of Environmental Engineering, The University of Kitakyushu, Kitakyushu, Fukuoka 808-0135, Japan.ORCID https://orcid.org/0000-0002-3691-3608
Hiroshi WakabayashiGraduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 606-0823, Japan.
Seigo KinuyaGraduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 606-0823, Japan.
Kazuma OgawaGraduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan.ORCID https://orcid.org/0000-0002-1691-7302

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SVS-1, a cationic amphiphilic peptide (CAP), adopts a β-hairpin conformation only upon interacting with the surface of cancer cells, thereby disrupting their membrane. Previously, we developed [

Identifiers

PMID42756818
PMCPMC13584574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.